XETR
ACT
Market cap1.98bUSD
Jul 09, Last price
170.90EUR
1D
1.12%
1Q
-1.38%
Jan 2017
12.43%
Name
Alzchem Group AG
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
AlzChem Group AG, an entity operating with its subsidiaries, is a globally active chemical company. It focuses on the development, manufacturing, and distribution of a wide array of chemical products across Germany, the European Union, the broader European continent, Asia, the NAFTA region, and other international markets. The company's operations are divided into three core segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. Its product portfolio is extensive, featuring human dietary supplements such as Creapure and Alipure, alongside LIVADUR-branded creatine supplements. For animal nutrition, it provides guanidinoacetic acid under the Creamino brand. The pharmaceutical sector is served by its Bioselect products. Industrially, AlzChem supplies DYHARD curing agents and accelerators, essential for applications in adhesives, powder coatings, printed circuit boards, and composites. It also manufactures SILZOT silicon nitride, a material used in ceramics, electronics, and solar technology. Further offerings include a variety of fine and specialty chemicals based on compounds like calcium carbide, calcium cyanamide, hydrogen cyanamide, dicyandiamide, guanidine, guanamines, nitroguanidine, as well as aromatic and aliphatic nitriles. Specific agricultural products include PERLKA calcium cyanamide, ALZOGUR germicide for pig pens, Dormex and Sitofex plant growth regulators, and BREAK-THRU plant protection additives. The company also provides products vital for industrial processes such as hot metal desulfurization and secondary metallurgy, in addition to technical gases. Beyond manufacturing, AlzChem Group AG is involved in managing chemical park operations, delivering administrative support, and supplying various infrastructure services. The company was founded in 1908 and is headquartered in Trostberg, Germany.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||